Mitochondria-Associated Gene SLC25A32 as a Novel Prognostic and Immunotherapy Biomarker: From Pan-Cancer Multiomics Analysis to Breast Cancer Validation

Figure 6

SLC25A32 immune infiltration analysis in pan-carcinoma. (a) TIMER2.0 database analysis determined the relationship between SLC25A32 expression and immune infiltration of tumour-associated fibroblasts in pan-cancer. (b) A similar approach was used to analyse the relationship between SLC25A32 expression and B-cell immune infiltration in pan-carcinoma. (c) The relationship between SLC25A32 expression and immune infiltration of CD8 T cells in pan-cancer was analysed. (d) The relationships between SLC25A32 expression and CD4 T cells, Th 1, and Th 2 immune infiltration in pan-cancer were analysed. (e) Correlation analysis of integrated SLC25A32 expression with 20 immune-infiltrating cells in pan-carcinoma using UCSCXenaShiny. (f) Radar plot of the correlation between mRNA SLC25A32 expression and different levels of tumour stemness. (g, h) Radar plots displaying the correlation of SLC25A32 expression with TMB/MSI in pan-cancer. ; ; .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)